Characterization of renal ecto-phosphodiesterase

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 2, 2007, Pages 810-815

  Jackson, Edwin K ^a   Ren, Jin ^a   Zacharia, Lefteris C ^a   Mi, Zaichuan ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; 1,3 ISOBUTYL 1 METHYLXANTHINE; 2 METHYL 5 NITROBENZENESULFONIC ACID DIMETHYLAMIDE; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 8 METHOXYMETHYL 3 ISOBUTYL 1 METHYLXANTHINE; 9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE PHOSPHATE; CYCLIC AMP; DIPYRIDAMOLE; ECTO PHOSPHODIESTERASE; MILRINONE; PHOSPHODIESTERASE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE III; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IX; PHOSPHODIESTERASE V; PHOSPHODIESTERASE VI; PHOSPHODIESTERASE VII; PHOSPHODIESTERASE X; PHOSPHODIESTERASE XI; SPLEEN EXONUCLEASE; UNCLASSIFIED DRUG; ZAPRINAST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME ANALYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

1-METHYL-3-ISOBUTYLXANTHINE; 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADENOSINE MONOPHOSPHATE; ANIMALS; CYCLIC AMP; DIPYRIDAMOLE; KIDNEY; MALE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; RATS;

EID: 34247236765     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.119057     Document Type: Article

References (40)

1. Bader S, Kortholt A, Snippe H, and Van Haastert PJM (2006) DdPDE4, a novel cAMP-specific phosphodiesterase at the surface of Dictyostelium cells. J Biol Chem 281:20018-20026.
2. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, and Naylor AM (1998) Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159:2164-2171.
3. Barber R and Butcher RW (1981) The quantitative relationship between intracellular concentration and egress of cyclic AMP from cultured cells. Mol Pharmacol 19:38-43.
4. Beavo JA and Reifsnyder DH (1990) Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Tends Pharmacol Sci 11:150-155.
5. Beavo JA, Rogers NL, Crofford OB, Hardman JG, Sutherland EW, and Newman EV (1970) Effects of xanthine derivatives on lipolysis and on adenosine 3′,5′-monophosphate phosphodiesterase activity. Mol Pharmacol 6:597-603.
6. Bender AT and Beavo JA (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58:488-520.
7. Deussen A, Lloyd HG, and Schrader J (1989) Contribution of S-adenosylhomocysteine to cardiac adenosine formation. J Mol Cell Cardiol 21:773-782.
8. Dubey RK, Gillespie DG, Mi Z, and Jackson EK (2001) Endogenous cyclic AMPadenosine pathway regulates cardiac fibroblast growth. Hypertension 37:1095-1100.
9. Dubey RK, Gillespie DG, Mi Z, Rosselli M, Keller PJ, and Jackson EK (2000) Estradiol inhibits smooth muscle cell growth in part by activating the cAMPadenosine pathway. Hypertension 35:262-266.
10. Dubey RK, Mi Z, Gillespie DG, and Jackson EK (1996) Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth. Hypertension 28:765-771.
11. Fawcett L, Baxendale R, Stacey P, McGrouther C, Harrow I, Soderling S, Hetman J, Beavo JA, and Phillips SC (2000) Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A. Proc Natl Acad Sci USA 97:3702-3707.
12. Finnegan RB and Carey GB (1998) Characterization of cyclic AMP efflux from swine adipocytes in vitro. Obes Res 6:292-298.
13. Gamanuma M, Yuasa K, Sasaki T, Sakurai N, Kotera J, and Omori K (2003) Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans. Cell Signal 15:565-574.
14. Gordon JL (1986) Extracellular ATP: Effects, sources and fate. Biochem J 233:309-319.
15. Harrison SA, Reifsnyder DH, Gallis B, Cadd GG, and Beavo JA (1986) Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Mol Pharmacol 29:506-514.
16. Hong KW, Shin HK, Kim HH, Choi JM, Rhim BY, and Lee WS (1999) Metabolism of cAMP to adenosine: Role in vasodilation of rat pial artery in response to hypotension. Am J Physiol 276:H376-H382.
17. Jackson EK (1991) Adenosine: a physiological brake on renin release. Annu Rev Pharmacol Toxicol 31:1-35.
18. Jackson EK (1997) Renal actions of purines, in Purinergic Approaches in Experimental Therapeutics (Jacobson KA and Jarvis MF eds) pp 217-250, Wiley-Less, New York.
19. Jackson EK (2001) P1 and P2 receptors in the renal system, in Handbook of Experimental Pharmacology, Volume 151/II, Purinergic and Pyrimidinergic Signalling II: Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function (Abbracchio MP and Williams M eds) p 33-71, Springer-Verlag, Berlin, Germany.
20. Jackson EK and Dubey RK (2001) Role of the extracellular cyclic AMP-adenosine pathway in renal physiology. Am J Physiol 281:F597-F612.
21. Jackson EK and Dubey RK (2004) The extracellular cyclic AMP-adenosine pathway in renal physiology. Annu Rev Physiol 66:571-599.
22. Jackson EK, Mi Z, Carcillo JA, Gillespie DG, and Dubey RK (1997) Phosphodiesterases in the rat renal vasculature. J Cardiovasc Pharmacol 30:798-801.
23. Jackson EK, Mi Z, Zhu C, and Dubey RK (2003) Adenosine biosynthesis in the collecting duct. J Pharmacol Exp Ther 307:888-896.
24. Jackson EK, Zacharia LC, Zhang M, Gillespie DG, Zhu C, and Dubey RK (2006) cAMP-adenosine pathway in the proximal tubule. J Pharmacol Exp Ther 317:1219-1229.
25. King CD and Mayer SE (1974) Inhibition of egress of adenosine 3′,5′-monophosphate from pigeon erythrocytes. Mol Pharmacol 10:941-953.
26. LeRoy EC, Ager A, and Gordon JL (1984) Effects of neutrophil elastase and other proteases on porcine aortic endothelial prostaglandin I2 production, adenine nucleotide release, and responses to vasoactive agents. J Clin Investig 74:1003-1010.
27. Lloyd HG, Deussen A, Wuppermann H, and Schrader J (1988) The transmethylation pathway as a source for adenosine in the isolated guinea-pig heart. Biochem J 252:489-494.
28. Lugnier C (2006) Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. Pharmacol Ther 109:366-398.
29. Mi Z and Jackson EK (1995) Metabolism of exogenous cyclic AMP to adenosine in the rat kidney. J Pharmacol Exp Ther 273:728-733.
30. Mi Z and Jackson EK (1998) Evidence for an endogenous cAMP-adenosine pathway in the rat kidney. J Pharmacol Exp Ther 287:926-930.
31. Misumi Y, Ogata S, Hirose S, and Ikehara Y (1990) Primary structure of rat liver 5′-nucleotidase deduced from the cDNA. J Biol Chem 265:2178-2183.
32. Pearson JD, Carleton JS, and Gordon JL (1980) Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. Biochem J 190:421-429.
33. Pearson JD and Gordon JL (1979) Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature (Lond) 281:384-386.
34. Resta R, Yamashita Y, and Thompson LF (1998) Ecto-enzyme and signaling functions of lymphocytic CD73. Immunol Rev 161:95-109.
35. Rybalkin SD and Bornfeldt KE (1999) Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation. Thromb Haemost 82:424-434.
36. Schrader J (1991) Formation and metabolism of adenosine and adenine nucleotides in cardiac tissue, in Adenosine and Adenine Nucleotides as Regulators of Cellular Function (Phillis JW, ed) pp 55-69, CRC Press, Boca Raton, FL.
37. Tofovic SP, Branch KR, Oliver RD, Magee WD, and Jackson EK (1991) Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther 256:850-860.
38. Wells JN and Miller JR (1988) Methylxanthine inhibitors of phosphodiesterase. Methods Enzymol 159:489-496.
39. Zacher LA and Carey GB (1999) Cyclic AMP metabolism by swine adipocyte microsomal and plasma membranes. Comp Biochem Physiol B 124:61-71.
40. Zimmermann H (1992) 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 285:345-365.